Novel aminobenzimidazoles as selective MCH-R1 antagonists for the treatment of metabolic diseases
摘要:
A series of novel aminobenzimidazoles was prepared and evaluated for h-MCH-R1 antagonist properties. Most of the compounds showed excellent h-MCH-R1 binding affinity as well as mouse ex vivo binding. Compounds 9 and 18 were active in mouse DIO studies at 30 mpk. (c) 2006 Elsevier Ltd. All rights reserved.